At Cambridge Biotherapies, we offer intravenous ketamine treatment for patients in the Boston area.
Ketamine is a validated and advanced form of therapy that is highly effective for treating mood and anxiety disorders that do not respond to traditional methods. In fact, in close to 75% of cases, ketamine therapy provides relief from the symptoms of depression
, post-traumatic stress disorder (PTSD)
, and obsessive-compulsive disorder.
Sometimes, this relief is found just hours after a single infusion. Contact us today
to schedule a consultation, and discover how the warm, supportive environment of our Boston area ketamine clinic can help you take the first steps towards recovery.
What is Ketamine?
When it comes to depression
treatment, timing is critical. Common antidepressants (such as Zoloft, Wellbutrin, and Cymbalta) can work—but they usually take anywhere from 4 to 6 weeks to achieve their full effect.
Ketamine is different. It is a fast-acting antidepressant that can substantially reduce depression symptoms in hours or days, rather than weeks.
So what makes ketamine so different? While most common antidepressants work by affecting the serotonin, dopamine, and norepinephrine transmitters, ketamine is a selective antagonist of the NMDA receptor and primarily affects the glutamate neurotransmitter system. This change might seem small, but the positive impacts on mental health are profound.
How Does Ketamine Work?
According to the monoamine hypothesis, depressive symptoms are mainly related to a deficit in the availability of monoamine neurotransmitters, and most antidepressant drugs are believed to modulate these neurotransmitter systems (e.g., norepinephrine, dopamine, or serotonin). However, the therapeutic effects of these common antidepressant medications emerge only after 4-12 weeks of treatment. Ketamine, on the other hand, exerts rapid antidepressant effects. These advanced pharmacological agents are desperately need in clinical practice.
When used to treat depression and anxiety, ketamine has a different mechanism of action from standard antidepressants. Ketamine acts by blocking N–methyl–d–aspartate (NMDA) receptors in the brain, which interact with the neurotransmitter glutamate. A 2018 article in the journal Nature concluded that depression is associated with increased burst activity in a part of the brain called the lateral habenula, which is essentially the “anti-reward center.” As a rapid antidepressant, ketamine works by blocking NMDA receptors in the lateral habenula. The resulting chemical changes in the brain are not yet fully understood, but it likely involves ketamine-induced gene expression and signaling cascades that continue to act long after the drug has been eliminated from the body.
Is Ketamine Effective?
Across multiple studies, ketamine has been shown to have an immediate and marked antidepressant effect for the majority of patients. Ketamine can substantially reduce or eliminate the most acute and distressing symptoms of depression
(such as thoughts of suicide), and in numerous research studies worldwide, the administration of six doses over several weeks has yielded a pronounced effect on severe depression. This pronounced effect is even in seen in otherwise treatment-resistant depression. Although the duration of this effect varies substantially among individuals, the repeated administration of ketamine produces a more pronounced and longer-lasting effect.
Of note, ketamine has been shown to induce neurogenesis (the creation of new nerve cells in the brain) beginning within two hours of administration. Additionally, exposure to ketamine has long-lasting effects on the activation of newly formed neurons in a part of the brain called the hippocampus (which regulates the formation of new memories).
At Cambridge Biotherapies, we remain vigilant about current research and work closely with other treatment providers to create individual ketamine treatment plans.
Ketamine and the Reduction of Suicide Risk
Based on three open-label studies, ketamine was found to be effective at reducing suicidality in treatment resistant depression (TRD) patients. Suicidal ideation in TRD patients improved in numerous cases after only a few minutes of ketamine infusion and remained stable for up to 4 hours post–infusion.
These findings have been replicated in patients with treatment-resistant bipolar depression by Zarate et al. In this randomized double-blind placebo-controlled crossover study, 79% of subjects were reported to respond to ketamine at some point during the 2-week trial (although the effects of ketamine waned from days 7-10 and there was no significant difference compared to placebo at that point).
Side Effects of Ketamine
Ketamine isn’t like typical cutting-edge treatments. It has been used for many years in other medical settings, and the safety and potential side-effects are well known. Across multiple studies, adverse side effects are uncommon—however, some patients do report nausea during treatment, which can be quickly alleviated using an IV medication called ondansetron. Other additional adverse effects include drowsiness, dizziness, poor coordination, and feelings of strangeness or unreality during the infusion. Variation in blood pressure during treatment can also occur, but these variations are often not clinically significant.
For many years, ketamine has been used as an anesthetic in higher doses. As an anesthetic, ketamine is particularly favored for children and mobile surgical units because it generally does not suppress breathing and has such minimal side effects. It is also on the World Health Organization’s List of Essential Medicines, which includes the safest and most effective medicines needed in most health systems.
The long-term side effects of ketamine are not fully known, but there have been no reports of significant medical concerns associated with the use of sub-anesthetic doses administered for a limited time (such as in the treatment of depression).
Throughout each patient’s course of ketamine treatment at Cambridge Biotherapies, our qualified highly qualified medical professionals will monitor any physical or mental side effects.
How is Ketamine Administered?
At Cambridge Biotherapies’ Boston area ketamine clinic, we believe in providing treatment in a setting that is comfortable and conducive to healing. Over a period of 40 minutes, our highly qualified nurses will administer a dose of ketamine through an IV; the size of this dose is determined by the patient’s weight, and as it’s designed to treat depression
rather than aid during surgery, it is substantially lower than the doses used for anesthesia. This means there is no loss of consciousness and the patient remains awake throughout each treatment.
During the infusion, some patients experience odd perceptions, like seeing bright colors. Some report what is referred to as a "dissociative" or "out of body" experience. Most patients tolerate these experiences with no trouble, and many even find them pleasant. Once the infusion is complete, the dissociative effects of the drug rapidly dissipate.
The most thoroughly studied treatment schedule is six infusions over 2-4 weeks. The experience of the first infusion is typically the most intense, and after treatment, patients tend to require variable amounts of time to feel fully comfortable resuming their normal activity. As the treatment schedule progresses, patients will generally leave the office within 30 minutes of an infusion and feel quite normal.
Cambridge Biotherapies prescribes intranasal ketamine for patients on a case-by-case basis. While there is very little empirically-validated evidence available to support the use of intranasal ketamine for depression and anxiety, we have found that home use of ketamine as a nasal spray can be of benefit to many patients, especially for those who have already experienced a decrease in their symptoms following a series of IV infusions.
Meanwhile, for some patients, we may prescribe intranasal ketamine as a substitute for the standard series of six IV infusions. Again, this is on a case-by-case basis. For home use of ketamine in this manner, we require that patients have an initial evaluation with one of our psychiatrists followed by at least one IV infusion. We then monitor each patient at our clinic during one intranasal treatment to ensure that there are no adverse side effects. Patients are then seen on a monthly basis, and prescriptions for the intranasal formulation are continued as needed.